ClinicalTrialsFinder

BRAF V600K Mutation Present Clinical Trials in Columbus, Ohio

1 recruitingColumbus, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 1

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Thyroid Gland Anaplastic CarcinomaBRAF NP_004324.2:p.V600EBRAF V600K Mutation Present
City of Hope Medical Center6 enrolled3 locationsNCT03975231